Drug Shortage Report for BREVICON 1/35 TABLETS (21-DAY PACK)
Report ID | 230652 |
Drug Identification Number | 02189054 |
Brand name | BREVICON 1/35 TABLETS (21-DAY PACK) |
Common or Proper name | BREVICON 1/35 |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL NORETHINDRONE |
Strength(s) | 0.035MG 1MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1x21 BLST |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-09-01 |
Actual start date | 2024-10-03 |
Estimated end date | 2025-02-19 |
Actual end date | 2025-02-03 |
Shortage status | Resolved |
Updated date | 2025-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2025-02-04 | English | Compare |
v15 | 2025-02-03 | French | Compare |
v14 | 2025-02-03 | English | Compare |
v13 | 2025-01-14 | French | Compare |
v12 | 2025-01-14 | English | Compare |
v11 | 2024-11-07 | French | Compare |
v10 | 2024-11-07 | English | Compare |
v9 | 2024-10-07 | French | Compare |
v8 | 2024-10-07 | English | Compare |
v7 | 2024-09-02 | English | Compare |
v6 | 2024-07-31 | French | Compare |
v5 | 2024-07-31 | English | Compare |
v4 | 2024-06-14 | French | Compare |
v3 | 2024-06-14 | English | Compare |
v2 | 2024-06-14 | French | Compare |
v1 | 2024-06-14 | English | Compare |
Showing 1 to 16 of 16